Insider Buying: CVS Group (LON:CVSG) Insider Purchases £9,978.90 in Stock

CVS Group plc (LON:CVSG) insider Robin Alfonso purchased 870 shares of the business’s stock in a transaction on Monday, November 17th. The shares were purchased at an average price of GBX 1,147 per share, with a total value of £9,978.90.

CVS Group Price Performance

LON CVSG opened at GBX 1,138 on Thursday. The company has a 50-day moving average price of GBX 1,273.99 and a 200-day moving average price of GBX 1,254.29. CVS Group plc has a 52 week low of GBX 791 and a 52 week high of GBX 1,648. The company has a quick ratio of 0.90, a current ratio of 1.09 and a debt-to-equity ratio of 110.52. The firm has a market capitalization of £814.76 million, a P/E ratio of 15.46, a PEG ratio of 1.77 and a beta of 1.02.

CVS Group (LON:CVSG) last announced its earnings results on Tuesday, October 7th. The company reported GBX 80.10 earnings per share (EPS) for the quarter. CVS Group had a net margin of 3.20% and a return on equity of 7.86%. Equities research analysts anticipate that CVS Group plc will post 93.9393939 earnings per share for the current year.

Wall Street Analyst Weigh In

CVSG has been the subject of a number of recent research reports. Jefferies Financial Group boosted their price objective on shares of CVS Group from GBX 1,250 to GBX 1,420 and gave the company a “hold” rating in a research report on Wednesday, October 22nd. Deutsche Bank Aktiengesellschaft boosted their price target on CVS Group from GBX 1,500 to GBX 1,700 and gave the company a “buy” rating in a report on Tuesday, October 21st. Berenberg Bank restated a “buy” rating and issued a GBX 2,000 price target on shares of CVS Group in a research report on Tuesday. Peel Hunt reaffirmed a “buy” rating and issued a GBX 1,600 price objective on shares of CVS Group in a research note on Tuesday. Finally, Royal Bank Of Canada boosted their price objective on CVS Group from GBX 1,500 to GBX 1,900 and gave the company an “outperform” rating in a research note on Tuesday, October 21st. Four analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of GBX 1,724.

About CVS Group

CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.